wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35051306-35032C2F-F36E-4958-8051-66CA1B21CCEB
Q35051306-35032C2F-F36E-4958-8051-66CA1B21CCEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35051306-35032C2F-F36E-4958-8051-66CA1B21CCEB
Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing state.
P2860
Q35051306-35032C2F-F36E-4958-8051-66CA1B21CCEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35051306-35032C2F-F36E-4958-8051-66CA1B21CCEB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f11af205cd7525420fdc1080229e6ddbcd7f452
P2860
Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatin